Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

about

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q42199801

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@en

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@nl

type

Item

label

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@en

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@nl

prefLabel

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@en

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@nl

P1476

Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.

@en

P2093

Dalia F Mohamed

http://www.w3.org/2001/XMLSchema#string

Reem A Habeeb

http://www.w3.org/2001/XMLSchema#string

Shafika E Ebrahim

http://www.w3.org/2001/XMLSchema#string

Sherin M Hosny

http://www.w3.org/2001/XMLSchema#string

P2860

Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Exhausted cytotoxic control of Epstein-Barr virus in human lupus.

Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality.

Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies

Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease.

Predictors of major infections in systemic lupus erythematosus.

Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers.

Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.

Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus.

P304

41-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMAMD.S15346

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25125988

http://www.w3.org/2001/XMLSchema#string

P932

4125374

http://www.w3.org/2001/XMLSchema#string